364 related articles for article (PubMed ID: 19373874)
1. Emerging drugs: mechanism of action, mass spectrometry and doping control analysis.
Thevis M; Thomas A; Kohler M; Beuck S; Schänzer W
J Mass Spectrom; 2009 Apr; 44(4):442-60. PubMed ID: 19373874
[TBL] [Abstract][Full Text] [Related]
2. Mass spectrometry of selective androgen receptor modulators.
Thevis M; Schänzer W
J Mass Spectrom; 2008 Jul; 43(7):865-76. PubMed ID: 18521833
[TBL] [Abstract][Full Text] [Related]
3. Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator andarine (S-4) for routine doping control purposes.
Thevis M; Thomas A; Fusshöller G; Beuck S; Geyer H; Schänzer W
Rapid Commun Mass Spectrom; 2010 Aug; 24(15):2245-54. PubMed ID: 20623476
[TBL] [Abstract][Full Text] [Related]
4. Detection of anabolic androgenic steroid abuse in doping control using mammalian reporter gene bioassays.
Houtman CJ; Sterk SS; van de Heijning MP; Brouwer A; Stephany RW; van der Burg B; Sonneveld E
Anal Chim Acta; 2009 Apr; 637(1-2):247-58. PubMed ID: 19286037
[TBL] [Abstract][Full Text] [Related]
5. Screening for metabolically stable aryl-propionamide-derived selective androgen receptor modulators for doping control purposes.
Thevis M; Kamber M; Schänzer W
Rapid Commun Mass Spectrom; 2006; 20(5):870-6. PubMed ID: 16470709
[TBL] [Abstract][Full Text] [Related]
6. New drugs and methods of doping and manipulation.
Thevis M; Kohler M; Schänzer W
Drug Discov Today; 2008 Jan; 13(1-2):59-66. PubMed ID: 18190865
[TBL] [Abstract][Full Text] [Related]
7. Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator S-22 to identify potential targets for routine doping controls.
Thevis M; Thomas A; Möller I; Geyer H; Dalton JT; Schänzer W
Rapid Commun Mass Spectrom; 2011 Aug; 25(15):2187-95. PubMed ID: 21710598
[TBL] [Abstract][Full Text] [Related]
8. Screening for 2-quinolinone-derived selective androgen receptor agonists in doping control analysis.
Thevis M; Kohler M; Maurer J; Schlörer N; Kamber M; Schänzer W
Rapid Commun Mass Spectrom; 2007; 21(21):3477-86. PubMed ID: 17985352
[TBL] [Abstract][Full Text] [Related]
9. Doping control analysis of tricyclic tetrahydroquinoline-derived selective androgen receptor modulators using liquid chromatography/electrospray ionization tandem mass spectrometry.
Thevis M; Kohler M; Thomas A; Schlörer N; Schänzer W
Rapid Commun Mass Spectrom; 2008 Aug; 22(16):2471-8. PubMed ID: 18634123
[TBL] [Abstract][Full Text] [Related]
10. Mass spectrometry of hydantoin-derived selective androgen receptor modulators.
Thevis M; Kohler M; Schlörer N; Kamber M; Kühn A; Linscheid MW; Schänzer W
J Mass Spectrom; 2008 May; 43(5):639-50. PubMed ID: 18095383
[TBL] [Abstract][Full Text] [Related]
11. Medicine and science in the fight against doping in sport.
Catlin DH; Fitch KD; Ljungqvist A
J Intern Med; 2008 Aug; 264(2):99-114. PubMed ID: 18702750
[TBL] [Abstract][Full Text] [Related]
12. Mass spectrometry in sports drug testing: Structure characterization and analytical assays.
Thevis M; Schänzer W
Mass Spectrom Rev; 2007; 26(1):79-107. PubMed ID: 16888758
[TBL] [Abstract][Full Text] [Related]
13. Emerging drugs--potential for misuse in sport and doping control detection strategies.
Thevis M; Schänzer W
Mini Rev Med Chem; 2007 May; 7(5):531-7. PubMed ID: 17504189
[TBL] [Abstract][Full Text] [Related]
14. Electron ionization mass spectrometry of the ryanodine receptor-based Ca(2+)-channel stabilizer S-107 and its implementation into routine doping control.
Thevis M; Beuck S; Thomas A; Fusshöller G; Sigmund G; Schlörer N; Rodchenkov G; Schäfer M; Schänzer W
Rapid Commun Mass Spectrom; 2009 Aug; 23(15):2363-70. PubMed ID: 19575395
[TBL] [Abstract][Full Text] [Related]
15. Synthetic anabolic agents: steroids and nonsteroidal selective androgen receptor modulators.
Thevis M; Schänzer W
Handb Exp Pharmacol; 2010; (195):99-126. PubMed ID: 20020362
[TBL] [Abstract][Full Text] [Related]
16. History of mass spectrometry at the Olympic Games.
Hemmersbach P
J Mass Spectrom; 2008 Jul; 43(7):839-53. PubMed ID: 18570181
[TBL] [Abstract][Full Text] [Related]
17. Use of an electrochemically synthesised metabolite of a selective androgen receptor modulator for mass spectrometry-based sports drug testing.
Thevis M; Lohmann W; Schrader Y; Kohler M; Bornatsch W; Karst U; Schänzer W
Eur J Mass Spectrom (Chichester); 2008; 14(3):163-70. PubMed ID: 18708696
[TBL] [Abstract][Full Text] [Related]
18. Characterization of equine urinary metabolites of selective androgen receptor modulators (SARMs) S1, S4 and S22 for doping control purposes.
Hansson A; Knych H; Stanley S; Thevis M; Bondesson U; Hedeland M
Drug Test Anal; 2015 Aug; 7(8):673-83. PubMed ID: 25560998
[TBL] [Abstract][Full Text] [Related]
19. Analytical approaches for the detection of emerging therapeutics and non-approved drugs in human doping controls.
Thevis M; Schänzer W
J Pharm Biomed Anal; 2014 Dec; 101():66-83. PubMed ID: 24906629
[TBL] [Abstract][Full Text] [Related]
20. Mass spectrometric determination of insulins and their degradation products in sports drug testing.
Thevis M; Thomas A; Schänzer W
Mass Spectrom Rev; 2008; 27(1):35-50. PubMed ID: 18000882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
